|
|
Article: Luminex Gets FDA Clearance for an Update to the xTAG Respiratory Viral Panel Package Insert.
- Article from:
- Health & Beauty Close-Up
- Article date:
- July 16, 2009
CopyrightCOPYRIGHT 2009 Close-Up Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Luminex Corp., the worldwide provider of multiplexed solutions, announced that the U.S. Food and Drug Administration (FDA) has cleared labeling updates for the company's xTAG Respiratory Viral Panel (RVP) to include data about the performance of the test in humans infected with the pandemic strain of influenza A, influenza A/H1N1, which is sometimes referred to as "swine flu."
In a release, the company noted:
The test's labeling has been updated to include information from two new studies that demonstrate that xTAG RVP can be an effective aid in the detection of 2009 Influenza A/HIN1, but cannot identify the hemagglutinin gene of the 2009 Influenza ...